Last reviewed · How we verify

mannitol 20% intravenous fluid — Competitive Intelligence Brief

mannitol 20% intravenous fluid (mannitol 20% intravenous fluid) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Osmotic diuretic. Area: Neurology, Ophthalmology, Critical Care.

marketed Osmotic diuretic Neurology, Ophthalmology, Critical Care Small molecule Live · refreshed every 30 min

Target snapshot

mannitol 20% intravenous fluid (mannitol 20% intravenous fluid) — Ain Shams University. Mannitol is an osmotic diuretic that draws fluid from tissues into the intravascular space and increases urine output to reduce intracranial and intraocular pressure.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
mannitol 20% intravenous fluid TARGET mannitol 20% intravenous fluid Ain Shams University marketed Osmotic diuretic
Aridol Kit Mannitol Baxter marketed Osmotic diuretic Glomerular filtrate osmolarity; tubular reabsorption of water 1964-01-01
Mannitol Mannitol Baxter marketed Osmotic diuretic Glomerular filtrate osmolarity; intracellular water movement 1964-01-01
Aridol Kit Mannitol Baxter marketed Osmotic diuretic Glomerular filtrate osmolarity; tubular reabsorption of water 1964-01-01
Aridol Kit Mannitol Baxter marketed Osmotic diuretic Glomerular filtrate osmolarity; tubular reabsorption of water 1964-01-01
Aridol Kit MANNITOL Baxter marketed Osmotic Diuretic [EPC] sodium channels 1964-01-01
variation of mannitol dose variation of mannitol dose University Hospital, Grenoble marketed Osmotic diuretic

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Osmotic diuretic class)

  1. Baxter · 4 drugs in this class
  2. Centre Hospitalier Universitaire de Besancon · 1 drug in this class
  3. Pfizer Inc. · 1 drug in this class
  4. Thiogenesis Therapeutics, Inc. · 1 drug in this class
  5. University Hospital, Grenoble · 1 drug in this class
  6. University Hospital, Saarland · 1 drug in this class
  7. Ain Shams University · 1 drug in this class
  8. University of Aarhus · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). mannitol 20% intravenous fluid — Competitive Intelligence Brief. https://druglandscape.com/ci/mannitol-20-intravenous-fluid. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: